Annual Drug Patent Expirations for TRILEPTAL
Trileptal is a drug marketed by Novartis and is included in two NDAs. It is available from three suppliers. There is one patent protecting this drug and two Paragraph IV challenges.
Drug patent litigation for TRILEPTAL.
The generic ingredient in TRILEPTAL is oxcarbazepine. Three suppliers are listed for this compound. Additional details are available on the oxcarbazepine profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
